Although specific investigations in FLT3-mutated disease remain sparse, comprehensive AML metabolomic analyses reveal enhanced expression of key enzymes including MTHFD2—a pivotal regulator of folate-mediated one-carbon transfer—alongside increased PPP activity, supporting cellular expansion under oncogenic conditions [114,115]. Here, FLT3 is linked to acute myeloid leukemia.